Abiopharma

News list

FDA updates labeling for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE

FDA Approval
Dec. 31, 2025, 13:45 UTC

Labeling changes approved for PHARMOBEDIENT. Active ingredient: ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE. Decision date: 12/22/2025

Full text

Register to leave comments
There are no comments here yet...